Literature DB >> 17585195

[Carcinoma with predominant lymphoid stroma in hepatobiliary system--report of 2 cases].

Hye Sook Min1, Eun Shin, Ja June Jang.   

Abstract

Lymphoepithelioma-like carcinoma (LELC) is an undifferentiated carcinoma with predominant lymphocytic infiltration, which is associated with Epstein-Barr virus (EBV) in variable proportions. We report two cases of carcinoma with predominant lymphoid stroma in hepatobiliary system. The first case was a lymphoepithelioma-like undifferentiated carcinoma with focal differentiation of cholangiocarcinoma (cytokeratin 19+) and hepatocellular carcinoma in light microscopy. The infiltration of CD8+ T lymphocytes was observed in the tumor and the surrounding hepatic parenchyme. In this tumor, EBV was detected and LMP1 was positive immunohistochemically. The second case showed the mixed features of lymphoepithelioma-like carcinoma and cholangiocarcinoma with predominant lymphoid stroma. In this case, EBV was detected. LELC of hepatobiliary system is an entity distinguished from conventional carcinoma with lymphoid stroma, and its association with EBV warrants further research.

Entities:  

Mesh:

Year:  2007        PMID: 17585195

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  3 in total

1.  MRI findings of uncommon non-hepatocyte origin primary liver tumours with pathological correlation.

Authors:  Y C Kim; M-S Park; Y E Chung; M-J Kim; Y N Park; J-H Kang; K A Kim; K W Kim
Journal:  Br J Radiol       Date:  2010-10-05       Impact factor: 3.039

2.  Intrahepatic lymphoepithelioma-like cholangiocarcinoma not associated with epstein-barr virus: a case report.

Authors:  Wonae Lee
Journal:  Case Rep Oncol       Date:  2011-02-14

Review 3.  Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review.

Authors:  Kai Zhang; Changcheng Tao; Zonggui Tao; Fan Wu; Songlin An; Jianxiong Wu; Weiqi Rong
Journal:  Diagn Pathol       Date:  2020-09-23       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.